Market Place
Sourcing Support
Oblique Therapeutics Advances NaV 1.8 Project To Next Stage
22 Oct 2024 //
PR NEWSWIRE
Oblique Therapeutics Partners With Eli Lilly On AbiProt® Technology
22 Aug 2024 //
PR NEWSWIRE
Oblique is delighted to announce appointment Christer Nordstedt M.D. PhD. as CEO
09 Nov 2022 //
PRNEWSWIRE
Oblique Therapeutics is excited to present the recent progress anti-Thioredoxin
13 Oct 2021 //
BIOSPACE
Oblique announces achievement of key milestone in its aKRAS-mAb program
27 Sep 2021 //
PRNEWSWIRE
Science Advances publishes proteomics technology from Oblique Therapeutics AB
19 Apr 2021 //
PRNEWSWIRE
Oblique together with collaborators at Sahlgrenska University Hospital
08 Oct 2020 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.